HRMY
Harmony Biosciences Holdings
41.50$
-1.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +19.5% | +300.2% | +1.5% | +55.5% | +20.4% | +23.1% | +27.3% | |
| – | -63.7% | +734.7% | +8.2% | +40.7% | +12.7% | +28.4% | +56.6% | |
| – | -70.7% | +834.8% | +2.5% | +4.0% | +27.8% | +45.4% | +66.1% | |
| – | -70.7% | +834.8% | +2.5% | +37.9% | +9.4% | +32.2% | +66.0% | |
| – | – | +421.2% | +57.1% | +57.1% | +35.4% | +12.0% | +16.6% | |
| – | – | +251.4% | +15.9% | -3.0% | +24.8% | +34.2% | -25.6% | |
| – | -15.6% | -29.5% | -12.6% | -30.1% | – | – | – | |
| – | – | +124.9% | -11.3% | +11.8% | -14.8% | -17.4% | -21.1% | |
| – | +1,425.5% | +178.9% | -25.1% | +9.8% | +27.1% | -1.3% | +18.0% | |
| – | +175.1% | +576.3% | -60.0% | +46.7% | +107.6% | +6.9% | +44.0% | |
| – | – | – | – | -40.5% | +650.0% | +17.1% | +394.6% | |
| – | +335.0% | -59.8% | -60.8% | +278.2% | +368.3% | -22.5% | +28.7% | |
| – | – | +98.3% | -2.2% | -0.2% | -5.8% | -8.7% | -11.9% | |
| – | -114.2% | – | +91.9% | +116.0% | +15.9% | +41.1% | +32.0% | |
| – | – | – | – | – | – | – | +7,161.0% | |
| – | +29.3% | -9.2% | +2.3% | +3.2% | -1.2% | -4.1% | +1.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.